The long-term allograft survival has been attributed to the development of operational tolerance due different mechanisms as clonal deletion, anergy and immune regulation. Previous studies have demonstrated that tolerogenic dendritic cells play a key role in the induction and maintenance of the peripheral tolerance. Therapies based on tolerogenic DCs transfer, differentiated with pharmacological agents, are a promising strategy for transplantation tolerance induction while reducing dependency on immunosuppressive
